Radiotherapy with a Radiolabeled Somatostatin Analogue, [¹¹¹In‐DTPA‐d‐Phe¹]‐Octreotide

This publication has 10 references indexed in Scilit:

• Somatostatin-receptor imaging of human malignancies: A new era in the localization, staging, and treatment of tumors
  Gastroenterology, 1993
• Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support
  New England Journal of Medicine, 1993
• Radioimmunotherapy of B-Cell Lymphoma with [¹³¹I]Anti-B1 (Anti-CD20) Antibody
  New England Journal of Medicine, 1993
• Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue
  British Journal of Cancer, 1993
• [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
  Life Sciences, 1991
• Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms
  Cancer, 1991
• The development of new radiopharmaceuticals
  European Journal of Nuclear Medicine and Molecular Imaging, 1990
• Effects of immunoscintigraphy with monoclonal antibodies in assays of hormones and tumour markers.
  BMJ, 1989
• LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
  The Lancet, 1989